Where does Candid Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Candid Therapeutics's 1 recorded funding rounds.

Premier Alternatives

Candid Therapeutics

Drug Discovery · San Diego, CA · Founded 2024 · Privately Held (backing)

Operator of a biotechnology research designed to create novel, easy-to-administer therapies for autoimmune diseases. Candid Therapeutics is based in San Diego, CA and was founded in 2024. It was valued at $657 million at its Series B in Aug 2024, the last priced event on record. It has raised $445 million across 1 recorded round; the latest was a $370 million Series B in Aug 2024.

PMV mark · valuation

$657.0M

Oct 2026

Priced at

its Series B

Aug 2024

Total raised

$445.0M

Last round

Early Stage VC (Series B)

Aug 2024

Cap table — not yet on record

Candid Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on Candid Therapeutics

·36 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about Candid Therapeutics

Where does Candid Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Candid Therapeutics's 1 recorded funding rounds.